Follow along on social at @RealDrWorldWide on Instagram, TikTok, and Snapchat, @Agullo on X, or @AgulloPlasticSurgery on Facebook
A provider-directed plan often starts with an introductory concentration, such as 1% to 2%, once daily to assess tolerance
Related Topics Tirzepatide Deep Dive mechanism, clinical results, and comparison context Retatrutide vs Tirzepatide triple versus dual receptor comparison Semaglutide vs Tirzepatide direct comparison and evidence boundaries GLP-1 Dosing Optimizer split-frequency modeling and plasma curves Full Reconstitution Calculator all-peptide vial math and custom BAC volumes GLP-1 Lean Mass Guide protein, training, and body-composition evidence References Tirzepatide for non-diabetic obesity SURMOUNT-1, 72 weeks, 5/10/15 mg, weight -15.0/-19.5/-20.9% (treatment-regimen estimand), DXA and pulse in Table S7: Jastreboff NEJM 2022
KPV has moderate research volume with key studies in colitis, IBD, and dermatitis